HUP0102776A3 - Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release - Google Patents
Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf releaseInfo
- Publication number
- HUP0102776A3 HUP0102776A3 HU0102776A HUP0102776A HUP0102776A3 HU P0102776 A3 HUP0102776 A3 HU P0102776A3 HU 0102776 A HU0102776 A HU 0102776A HU P0102776 A HUP0102776 A HU P0102776A HU P0102776 A3 HUP0102776 A3 HU P0102776A3
- Authority
- HU
- Hungary
- Prior art keywords
- inhibitors
- human
- production
- acid derivatives
- hydroxamic acid
- Prior art date
Links
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9813451.3A GB9813451D0 (en) | 1998-06-22 | 1998-06-22 | Novel compounds |
| PCT/GB1999/001954 WO1999067201A1 (en) | 1998-06-22 | 1999-06-22 | Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0102776A2 HUP0102776A2 (hu) | 2001-12-28 |
| HUP0102776A3 true HUP0102776A3 (en) | 2002-11-28 |
Family
ID=10834177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0102776A HUP0102776A3 (en) | 1998-06-22 | 1999-06-22 | Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US6458779B1 (hu) |
| EP (1) | EP1089963B1 (hu) |
| JP (1) | JP2002518470A (hu) |
| KR (1) | KR20010053076A (hu) |
| CN (1) | CN1306508A (hu) |
| AP (1) | AP2000002001A0 (hu) |
| AR (1) | AR029303A1 (hu) |
| AT (1) | ATE269296T1 (hu) |
| AU (1) | AU744801B2 (hu) |
| BG (1) | BG105154A (hu) |
| BR (1) | BR9911423A (hu) |
| CA (1) | CA2335513A1 (hu) |
| DE (1) | DE69918113T2 (hu) |
| DK (1) | DK1089963T3 (hu) |
| EA (1) | EA200100065A1 (hu) |
| ES (1) | ES2222711T3 (hu) |
| GB (1) | GB9813451D0 (hu) |
| HK (1) | HK1025894A1 (hu) |
| HU (1) | HUP0102776A3 (hu) |
| ID (1) | ID27413A (hu) |
| IL (1) | IL139738A (hu) |
| MY (1) | MY121785A (hu) |
| NO (1) | NO20006349D0 (hu) |
| NZ (1) | NZ508229A (hu) |
| OA (1) | OA11639A (hu) |
| PL (1) | PL345038A1 (hu) |
| PT (1) | PT1089963E (hu) |
| SI (1) | SI1089963T1 (hu) |
| SK (1) | SK19562000A3 (hu) |
| TR (1) | TR200003877T2 (hu) |
| WO (1) | WO1999067201A1 (hu) |
| ZA (1) | ZA200007254B (hu) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020082200A1 (en) * | 1994-07-13 | 2002-06-27 | Smithkline Beecham P.1.C. | Use of inhibitors of human S-CD23 |
| US6716878B1 (en) * | 1999-04-09 | 2004-04-06 | Vernalis (Oxford) Limited | Antimicrobial agents |
| GB9925470D0 (en) * | 1999-10-27 | 1999-12-29 | Smithkline Beecham Plc | Novel compounds |
| GB9929527D0 (en) * | 1999-12-14 | 2000-02-09 | Smithkline Beecham Plc | Novel compounds |
| JP2003523994A (ja) * | 2000-02-24 | 2003-08-12 | スミスクライン ビーチャム パブリック リミテッド カンパニー | 新規ｃｄ２３インヒビター |
| WO2004076386A2 (en) | 2003-02-25 | 2004-09-10 | Topotarget Uk Limited | Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9223904D0 (en) * | 1992-11-13 | 1993-01-06 | British Bio Technology | Inhibition of cytokine production |
| GB9414157D0 (en) * | 1994-07-13 | 1994-08-31 | Smithkline Beecham Plc | Medical use |
| GB9507799D0 (en) | 1995-04-18 | 1995-05-31 | British Biotech Pharm | Metalloproteinase inhibitors |
| US5691381A (en) * | 1995-04-18 | 1997-11-25 | The Dupont Merck Pharmaceutical Company | Hydroxamic and carbocyclic acids as metalloprotease inhibitors |
| GB9513331D0 (en) * | 1995-06-30 | 1995-09-06 | British Biotech Pharm | Matrix metalloproteinase inhibitors |
| AU7335496A (en) * | 1995-10-23 | 1997-05-15 | Sankyo Company Limited | Hyroxamic acid derivatives |
| GB9609794D0 (en) * | 1996-05-10 | 1996-07-17 | Smithkline Beecham Plc | Novel compounds |
| WO1998043959A1 (en) * | 1997-03-28 | 1998-10-08 | Zeneca Limited | Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
-
1998
- 1998-06-22 GB GBGB9813451.3A patent/GB9813451D0/en not_active Ceased
-
1999
- 1999-06-22 CA CA002335513A patent/CA2335513A1/en not_active Abandoned
- 1999-06-22 ID IDW20002683A patent/ID27413A/id unknown
- 1999-06-22 CN CN99807653A patent/CN1306508A/zh active Pending
- 1999-06-22 BR BR9911423-2A patent/BR9911423A/pt not_active IP Right Cessation
- 1999-06-22 NZ NZ508229A patent/NZ508229A/en unknown
- 1999-06-22 SK SK1956-2000A patent/SK19562000A3/sk unknown
- 1999-06-22 KR KR1020007014549A patent/KR20010053076A/ko not_active Application Discontinuation
- 1999-06-22 AT AT99928068T patent/ATE269296T1/de not_active IP Right Cessation
- 1999-06-22 DE DE69918113T patent/DE69918113T2/de not_active Expired - Fee Related
- 1999-06-22 EA EA200100065A patent/EA200100065A1/ru unknown
- 1999-06-22 SI SI9930648T patent/SI1089963T1/xx unknown
- 1999-06-22 MY MYPI99002571A patent/MY121785A/en unknown
- 1999-06-22 AP APAP/P/2000/002001A patent/AP2000002001A0/en unknown
- 1999-06-22 IL IL13973899A patent/IL139738A/en not_active IP Right Cessation
- 1999-06-22 ES ES99928068T patent/ES2222711T3/es not_active Expired - Lifetime
- 1999-06-22 DK DK99928068T patent/DK1089963T3/da active
- 1999-06-22 AR ARP990102994A patent/AR029303A1/es unknown
- 1999-06-22 JP JP2000555856A patent/JP2002518470A/ja active Pending
- 1999-06-22 WO PCT/GB1999/001954 patent/WO1999067201A1/en not_active Application Discontinuation
- 1999-06-22 AU AU45195/99A patent/AU744801B2/en not_active Ceased
- 1999-06-22 EP EP99928068A patent/EP1089963B1/en not_active Expired - Lifetime
- 1999-06-22 PL PL99345038A patent/PL345038A1/xx not_active Application Discontinuation
- 1999-06-22 US US09/701,946 patent/US6458779B1/en not_active Expired - Fee Related
- 1999-06-22 HU HU0102776A patent/HUP0102776A3/hu unknown
- 1999-06-22 TR TR2000/03877T patent/TR200003877T2/xx unknown
- 1999-06-22 PT PT99928068T patent/PT1089963E/pt unknown
- 1999-06-22 OA OA1200000359A patent/OA11639A/en unknown
-
2000
- 2000-12-07 ZA ZA200007254A patent/ZA200007254B/en unknown
- 2000-12-13 NO NO20006349A patent/NO20006349D0/no not_active Application Discontinuation
-
2001
- 2001-01-15 BG BG105154A patent/BG105154A/bg unknown
- 2001-09-14 HK HK01106515A patent/HK1025894A1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL335027A1 (en) | Derivatives of arylsulphonylamino hydroxamic acid | |
| HK1048247B (zh) | 穩定的胡羅卜素-葉黃素小球組合物和使用方法 | |
| AU4520801A (en) | Novel substituted phenanthridinones and methods of use thereof | |
| EP1227821A4 (en) | THERAPEUTIC COMPOSITIONS AND METHOD FOR USE THEREOF | |
| EP1487776A4 (en) | ACID COMPOUNDS AND ESTERS AND METHODS OF USE THEREOF | |
| GB9507415D0 (en) | Production and uses of caffeic acid and derivatives thereof | |
| IL143594A0 (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases | |
| HK1044536A1 (en) | Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics | |
| AU2002220735A1 (en) | Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain | |
| IL156139A0 (en) | Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain | |
| IL139738A0 (en) | Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release | |
| HK1045260B (zh) | 15-羥基二十碳四烯酸雜原子阻斷類似物及其使用方法 | |
| IL149364A0 (en) | Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23 | |
| AU2002246926A1 (en) | 12-hydroxy-eicosatrienoic acid analogs and methods of use thereof | |
| GB9922710D0 (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis | |
| AU1872001A (en) | Hydroxamic acid derivatives as inhibitors of human cd23 and of the tnf release | |
| AU1101301A (en) | 2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use | |
| GB9817348D0 (en) | Pharmaceutical use of esters | |
| GB9828845D0 (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases | |
| SG78357A1 (en) | Production of acrylic acid and inhibition of polymerization thereof | |
| GB9411539D0 (en) | Production and uses of caffeic acid and derivatives thereof | |
| PT934307E (pt) | Compostos azabicíclicos substituídos e sua utilização como inibidores da produção de tnf e da fosfodiesterase do amp cíclico | |
| GB9922709D0 (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases | |
| AU7000600A (en) | Cinnamic acid nitrile method of production and use thereof | |
| PL324738A1 (en) | Method of obtaining monophtalic acid and its salts |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |